GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alnylam Pharmaceuticals, Inc. (ALNY) [hlAlert]

Rating:
Buy ALNY
up 281.59 %

Alnylam Pharmaceuticals, Inc. (ALNY) rated Buy

Posted on: Wednesday,  Dec 5, 2007  1:25 PM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Buy Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) on 12/05/2007. Previously Cantor Fitzgerald rated Buy Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) on
09/11/2007., when the stock price was $27.49. Since then, Alnylam Pharmaceuticals, Inc. has gained 281.59% as of 01/22/2016's recent price of $104.90.
If you would have followed the previous Cantor Fitzgerald's recommendation on ALNY, you would have gained 281.59% of your investment in 3055 days.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2007 1:25 PM Buy
None
30.57 37.00
as of 8/27/2015
1 Week down  -1.21 %
1 Month down  -20.18 %
3 Months down  -9.46 %
1 YTD up  63.14 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2007 9:25 AM Buy
None
27.49 32.00
8/17/2007 9:25 AM Hold
None
23.29 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy